3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 26 0 0 0 0 0 0 0999 V2000
2.5236 0.2191 1.4462 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9569 1.0925 -0.1240 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5277 0.1536 -0.2606 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6382 -0.5942 -0.4927 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7146 -0.5158 0.1218 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9272 0.0509 -0.8998 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6341 -1.9820 -0.3499 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5418 1.5510 -0.3997 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7005 -1.9132 0.2608 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8806 0.2319 0.3537 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5331 -2.6403 0.0260 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7092 2.2780 -0.1654 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8764 1.6197 0.2106 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8039 0.4488 0.2731 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5084 -0.6584 -1.5065 H 0 0 0 0 0 0 0 0 0 0 0 0
1.7749 0.9073 -1.5647 H 0 0 0 0 0 0 0 0 0 0 0 0
1.5346 -2.5649 -0.5253 H 0 0 0 0 0 0 0 0 0 0 0 0
0.3402 2.1214 -0.6741 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.6011 -2.4487 0.5540 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.8043 -0.2617 0.6487 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.5356 -3.7206 0.1379 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.7064 3.3589 -0.2727 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.7846 2.1864 0.3938 H 0 0 0 0 0 0 0 0 0 0 0 0
4.1707 1.2696 -1.1003 H 0 0 0 0 0 0 0 0 0 0 0 0
4.6365 1.4131 0.5576 H 0 0 0 0 0 0 0 0 0 0 0 0
1 14 2 0 0 0 0
2 14 1 0 0 0 0
2 24 1 0 0 0 0
2 25 1 0 0 0 0
3 4 1 0 0 0 0
3 5 1 0 0 0 0
3 8 2 0 0 0 0
4 6 1 0 0 0 0
4 7 2 0 0 0 0
5 9 1 0 0 0 0
5 10 2 0 0 0 0
6 14 1 0 0 0 0
6 15 1 0 0 0 0
6 16 1 0 0 0 0
7 11 1 0 0 0 0
7 17 1 0 0 0 0
8 12 1 0 0 0 0
8 18 1 0 0 0 0
9 11 2 0 0 0 0
9 19 1 0 0 0 0
10 13 1 0 0 0 0
10 20 1 0 0 0 0
11 21 1 0 0 0 0
12 13 2 0 0 0 0
12 22 1 0 0 0 0
13 23 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
2-naphthalen-1-ylacetamide
4.2 InChl
InChI=1S/C12H11NO/c13-12(14)8-10-6-3-5-9-4-1-2-7-11(9)10/h1-7H,8H2,(H2,13,14)
4.3 InChlKey
XFNJVKMNNVCYEK-UHFFFAOYSA-N
4.4 Canonical SMILES
C1=CC=C2C(=C1)C=CC=C2CC(=O)N
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病